Blockade of NF-κB by NP-mediated delivery of the NF-κB decoy attenuated inflammation and proliferation, attenuating the development of PAH and pulmonary arterial remodeling induced by monocrotaline [59]. This evidence concerns the gene NFKB1 and pulmonary arterial hypertension.